4 assets in Testicular Yolk Sac Tumor

Therapeutic assets addressing Testicular Yolk Sac Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Testicular Yolk Sac Tumor	Children's Oncology Group	P3	BB (66)
Bleomycin Testicular Yolk Sac Tumor	Children's Oncology Group	P3	B (60)
Cis-Diamminedichloroplatinum Ii Testicular Yolk Sac Tumor	Children's Oncology Group	P3	B (60)
Etoposide Testicular Yolk Sac Tumor	Children's Oncology Group	P3	B (60)